Korea Disease Control and Prevention Agency

Autism Specialists to Celebrate Grand Opening of New Therapy Clinic for Children in the Tri-State Area

Retrieved on: 
Mittwoch, Oktober 18, 2023
Child, Spectrum, Korea Disease Control and Prevention Agency, ABA, Caravel, Senior counsel, BCBA, Applied behavior analysis, Pediatrics, American Academy, Language, Diagnosis, MS, Pediatrics (journal), Nursing

DUBUQUE, Iowa, Oct. 18, 2023 /PRNewswire/ -- Caravel Autism Health , a leader in the diagnosis and treatment of young children on the autism spectrum, is hosting a ribbon-cutting ceremony on Thursday, October 19 to celebrate the grand opening of a new, state-of-the-art autism therapy clinic for families in the Tri-State area.

Key Points: 
  • DUBUQUE, Iowa, Oct. 18, 2023 /PRNewswire/ -- Caravel Autism Health , a leader in the diagnosis and treatment of young children on the autism spectrum, is hosting a ribbon-cutting ceremony on Thursday, October 19 to celebrate the grand opening of a new, state-of-the-art autism therapy clinic for families in the Tri-State area.
  • Caravel's team of specialists has been improving outcomes for children with autism since 2009.
  • We want to ensure that all children, including those in rural communities, have access to this life-changing treatment, so we're excited to celebrate the grand opening of our newest clinic."
  • "Early diagnosis is the best possible scenario for a child with autism," explained Hannah Bechen, MS, BCBA, clinic director for Caravel in Dubuque.

Autism Specialists to Celebrate Grand Opening of New Therapy Clinic for Children in the Tri-State Area

Retrieved on: 
Mittwoch, Oktober 18, 2023
Child, Spectrum, Korea Disease Control and Prevention Agency, ABA, Caravel, Senior counsel, BCBA, Applied behavior analysis, Pediatrics, American Academy, Language, Diagnosis, MS, Pediatrics (journal), Nursing

DUBUQUE, Iowa, Oct. 18, 2023 /PRNewswire/ -- Caravel Autism Health , a leader in the diagnosis and treatment of young children on the autism spectrum, is hosting a ribbon-cutting ceremony on Thursday, October 19 to celebrate the grand opening of a new, state-of-the-art autism therapy clinic for families in the Tri-State area.

Key Points: 
  • DUBUQUE, Iowa, Oct. 18, 2023 /PRNewswire/ -- Caravel Autism Health , a leader in the diagnosis and treatment of young children on the autism spectrum, is hosting a ribbon-cutting ceremony on Thursday, October 19 to celebrate the grand opening of a new, state-of-the-art autism therapy clinic for families in the Tri-State area.
  • Caravel's team of specialists has been improving outcomes for children with autism since 2009.
  • We want to ensure that all children, including those in rural communities, have access to this life-changing treatment, so we're excited to celebrate the grand opening of our newest clinic."
  • "Early diagnosis is the best possible scenario for a child with autism," explained Hannah Bechen, MS, BCBA, clinic director for Caravel in Dubuque.

Findhelp Partners with State of Colorado to Fight Spread of Infectious Diseases

Retrieved on: 
Mittwoch, Oktober 18, 2023
Infection, Korea Disease Control and Prevention Agency, Public health, Viral hepatitis, Colorado Department of Labor and Employment, HIV, Colorado Department of Public Health and Environment, Environment, Hepatitis A, Drug, Privacy, Diagnosis, Vaccine

Coloradans trust findhelp to connect them with the social care services they need.

Key Points: 
  • Coloradans trust findhelp to connect them with the social care services they need.
  • Nearly 560,000 users in the state have conducted 1.74 million searches on the findhelp platform.
  • "We are immensely grateful to CDPHE for allowing us to help with this crucial need," said Erine Gray, founder and CEO of findhelp.
  • In 2020, the state suffered an historic high of 1,477 fatal overdoses; in 2022, that number rose to 1,799.

New COPD State Briefs Highlight Burden by State, Opportunities to Improve

Retrieved on: 
Mittwoch, Oktober 18, 2023
Education, Korea Disease Control and Prevention Agency, Family, Treatment, Mortality, Disease, Research, American Lung Association, Emphysema, Tobacco, Spirometry, Vaccination, Risk, Public, Diagnosis, Chronic obstructive pulmonary disease, COPD, Pharmaceutical industry

CHICAGO, Oct. 18, 2023 /PRNewswire/ -- Today, the American Lung Association released the COPD State Briefs, which include data about prevention, diagnosis, health outcomes and treatment of the disease for all 50 states and Washington, D.C. The briefs also highlight the burden of chronic obstructive pulmonary disease (COPD) across the U.S., highlighting the states with the highest COPD rates and opportunities to improve the burden of the disease.

Key Points: 
  • The briefs also highlight the burden of chronic obstructive pulmonary disease (COPD) across the U.S., highlighting the states with the highest COPD rates and opportunities to improve the burden of the disease.
  • COPD , which includes chronic bronchitis and emphysema, is a long-term lung disease that makes it hard to breathe.
  • The COPD State Briefs were created with support by the Centers for Disease Control and Prevention.
  • Learn more and view the COPD State Briefs at Lung.org/COPD-briefs .

Leidos Partnership Deploys MHS GENESIS Overseas in First of Two Planned OCONUS Waves

Retrieved on: 
Dienstag, Oktober 17, 2023
Partnership, OCONUS, Department of Defense Serum Repository, Military Health System, Calendar, PEO, United Kingdom, CDC, California Substance Abuse Treatment Facility and State Prison, Corcoran, Waves, Dialysis, Department of Defence, Contiguous United States, DOD, MHS, DHMS, Korea Disease Control and Prevention Agency, Patient, Renewable energy, Mobile phone, Defense, Far East

RESTON, Va., Oct. 17, 2023 /PRNewswire/ -- The Leidos Partnership for Defense Health (LPDH) today announced it successfully delivered the MHS GENESIS electronic health record to an additional 9,000 Department of Defense (DOD) clinicians and providers as part of its first Outside of the Contiguous United States (OCONUS) deployment (Waves LANDSTUHL/LAKENHEATH). The current system deployment spans 10 Military Treatment Facilities (MTFs) across Europe and the United Kingdom. Additionally, LPDH deployed MHS GENESIS to users at Fort Buchanan, Puerto Rico and Guantanamo Bay, Cuba.

Key Points: 
  • Additionally, LPDH deployed MHS GENESIS to users at Fort Buchanan, Puerto Rico and Guantanamo Bay, Cuba.
  • With this latest overseas DOD wave deployment, the MHS GENESIS system is now operational at over 3,500 locations and now reaches over seven million DOD beneficiaries.
  • MHS GENESIS is 91% deployed to DOD garrison facilities and will next deploy to Far East locations in October 2023.
  • MHS GENESIS is being deployed across the continental United States and overseas through a total of 23 waves, with each wave targeting a specific region.

Wandercraft announces launch of US commercial operations with the start of Atalante X research at Kessler Foundation

Retrieved on: 
Donnerstag, Oktober 12, 2023
Partnership, Walking, National Multiple Sclerosis Society, Mobility, Engineering, Doctor of Philosophy, Gait, TIM, Stroke, Research, Rehabilitation, European Economic Area, ALS, Human, Freedom, Brain damage, FDA, Movement, European Union Centers of Excellence in the United States, Disability, Neurostimulation, CE, EEA, Multiple sclerosis, Kessler Foundation, Korea Disease Control and Prevention Agency, Patient, Tetraplegia, Management, Medical device, Nursing, EU

NEW YORK CITY, New York, 12 October 2023 -- Wandercraft, the developer of the world's first self-stabilizing walking exoskeleton, designed to enable people with walking impairments to stand and walk again, announced today the official launch of commercial operations in the United States with the start of Atalante X research at Kessler Foundation, a global leader in rehabilitation research.

Key Points: 
  • A large number of individuals with disabilities in the US may benefit from using the Atalante X exoskeleton.
  • In addition, approximately 302,000 people living in the United States have experienced a traumatic spinal cord injury according to the US National Spinal Cord Injury Statistical Center.
  • Finally, approximately one million people in the US are living with multiple sclerosis according to the National Multiple Sclerosis Society.
  • The CE marking represents a manufacturer's declaration that products comply with the EU's New Approach Directives.

CORRECTION: Lundquist Investigator Dr. Loren Miller Is the Lead Author of the “Universal Decolonization” Study Published in the New England Journal of Medicine

Retrieved on: 
Mittwoch, Oktober 11, 2023
Chlorhexidine, Infection, Methicillin-resistant Staphylococcus aureus, Nursing, Doctor of Philosophy, The New England Journal of Medicine, Prevalence, Epidemiology, UCI, Hospital, MPH, University of California, Irvine, University, CDC, Agency for Healthcare Research and Quality, University of California, Irvine School of Medicine, Health, Harbor–UCLA Medical Center, AHRQ, MHSA, Nursing home, Fungal infection, Long-term care, MRSA, Povidone-iodine, Houston, Clinical trial, Nose, Institute of Health and Biomedical Innovation, Korea Disease Control and Prevention Agency, Skin, UCI School of Biological Sciences, Urinary tract infection, Enterococcus-1 RNA motif, Bed, Research, NIH, Pharmaceutical industry, MD, Medicine

The findings were published on October 10, 2023, in the New England Journal of Medicine.

Key Points: 
  • The findings were published on October 10, 2023, in the New England Journal of Medicine.
  • “The cleansing protocol, called universal decolonization, substantially reduced the number of nursing home residents requiring hospitalization due to infection,” said lead author and Lundquist Investigator, Loren Miller, MD, MPH.
  • Dr. Miller is the Chief of Infectious Diseases at the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center in Torrance, California.
  • “Nursing Home Decolonization for Infection and Hospitalization Prevention” published in the New England Journal of Medicine on October 10, 2023: https://www.nejm.org/doi/full/10.1056/NEJMoa2215254?query=featured_home

New Bullying Prevention Handbook Developed for Youth Sport Coaches

Retrieved on: 
Mittwoch, Oktober 11, 2023
Parent, Sport, Student, Handbook, National Bullying Helpline, Anxiety, Bullying, Risk, Office of Inspector General, U.S. Department of Health and Human Services, Behavior, Human, United States Center for SafeSport, LGBTQ, Mental health, Depression, Korea Disease Control and Prevention Agency, Disability, U.S. Department of Defense Strategy for Operating in Cyberspace, Health Oriented Preventive Education, Athlete, Face, Nursing, Toy, Tutoring

Denver, Colorado, Oct. 11, 2023 (GLOBE NEWSWIRE) -- The U.S. Center for SafeSport (The Center) today released a new Bullying Prevention Handbook .

Key Points: 
  • Denver, Colorado, Oct. 11, 2023 (GLOBE NEWSWIRE) -- The U.S. Center for SafeSport (The Center) today released a new Bullying Prevention Handbook .
  • The handbook, which is tailored to coaches of minor athletes, provides useful tools to create safe and inclusive sporting environments for all athletes.
  • “Using the Center’s bullying prevention handbook, caring and engaged coaches can foster supportive environments to help athletes thrive on and off the field.”
    The handbook’s core themes focus on how to:
    Recognize Bullying Behavior: Coaches can learn how to identify bullying behaviors common in youth sports, which can be physical, verbal, sexual, cyber, and may even rise to the level of criminal conduct.
  • “We are providing coaches proven tools and tactics to create the most enriching sport experience possible for their players.”
    The handbook’s release coincides with National Stop Bullying Day during National Bullying Prevention Month, which is meant to raise awareness and educate the public about bullying and cyberbullying prevention.

Lundquist Investigator Dr. Loren Miller Is the Lead Author of the “Universal Decolonization” Study Published in the New English Journal of Medicine

Retrieved on: 
Dienstag, Oktober 10, 2023
Chlorhexidine, Infection, Methicillin-resistant Staphylococcus aureus, Nursing, Doctor of Philosophy, The New England Journal of Medicine, Prevalence, Epidemiology, UCI, Hospital, MPH, University of California, Irvine, CDC, University, Agency for Healthcare Research and Quality, University of California, Irvine School of Medicine, Health, Harbor–UCLA Medical Center, AHRQ, MHSA, Fungal infection, Long-term care, MRSA, Povidone-iodine, Houston, Clinical trial, Nose, Institute of Health and Biomedical Innovation, Korea Disease Control and Prevention Agency, Skin, UCI School of Biological Sciences, Urinary tract infection, Enterococcus-1 RNA motif, Bed, Research, NIH, Pharmaceutical industry, MD, Medicine

“The cleansing protocol, called universal decolonization, substantially reduced the number of nursing home residents requiring hospitalization due to infection,” said lead author and Lundquist Investigator, Loren Miller, MD, MPH.

Key Points: 
  • “The cleansing protocol, called universal decolonization, substantially reduced the number of nursing home residents requiring hospitalization due to infection,” said lead author and Lundquist Investigator, Loren Miller, MD, MPH.
  • Dr. Miller is the Chief of Infectious Diseases at the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center in Torrance, California.
  • Each year, 3 million healthcare-associated infections (HAIs) such as methicillin-resistant Staphylococcus aureus (MRSA), bloodstream and urinary tract infections occur in U.S. nursing homes.
  • The findings add to a growing body of Dr. Miller’s research that has been funded by NIH, AHRQ, and other federal sources.

Study Published in Science Translational Medicine Shows Exbaq’s Experimental Vaccine Protects Against Many of the Most Dangerous Antibiotic Resistant Superbugs Causing Hospital Acquired Infections

Retrieved on: 
Donnerstag, Oktober 5, 2023
Patent, Partnership, Klebsiella pneumoniae, Infection, Methicillin-resistant Staphylococcus aureus, Homeland, Homeland security, Innovation, Acinetobacter baumannii, IND, Fungus, National Institute of Allergy and Infectious Diseases, Fungal infection, Hulk, Laboratory, Pseudomonas aeruginosa, Patient, FDA, Mucormycosis, R01, Macrophage, Escherichia coli, Immune system, USC, Bangladesh Technical Education Board, Vancomycin-resistant Enterococcus, ESBL, Korea Disease Control and Prevention Agency, Blood, Enterococcus, Translational medicine, Denise Spellberg, NIH, Vaccine, Pharmaceutical industry, Klebsiella, Science

Multiple studies in different laboratories have confirmed the vaccine protected against serious infections within 24 hours and lasts for up to 28 days.

Key Points: 
  • Multiple studies in different laboratories have confirmed the vaccine protected against serious infections within 24 hours and lasts for up to 28 days.
  • Early data suggest that a second dose may extend the window to prevent infection.
  • The study was published in Science and Translational Medicine.
  • These infections are often caused by highly antibiotic-resistant superbugs, many of which are targeted by this new ExBaq vaccine.